Abstract: A valve assembly comprising a housing and a valve, the valve being disposed within the housing, a first indexed member integral to the housing, the first indexed member adapted to be complementary to a second indexed member, and a radio frequency identification device adapted to communicate with a radio frequency receiver, the valve being configured to align with a canister, seal the canister and open in a single movement. A drug containment device having said valve assembly is also disclosed.
Type:
Application
Filed:
September 15, 2023
Publication date:
January 18, 2024
Applicant:
Mallinckrodt Hospital Products IP Unlimited Company
Inventors:
Frederick J. Montgomery, Duncan P. Bathe, Daniel J. Lee, Scott I. Biba, Todd J. Bakken
Abstract: Described are methods of administering therapeutic gases comprising high concentrations of nitric oxide, particularly concentrations above 2,000 ppm. The therapeutic gas may be administered at a certain dosing rate, such as less than 166 micrograms of nitric oxide per second. Also described are methods of administering a therapeutic gas comprising nitric oxide to a patient, wherein a dose of nitric oxide is administered from a portable device that includes a delivery system and a mini-cylinder. Methods of intermittent administration of nitric oxide pulses are also described.
Type:
Application
Filed:
April 19, 2023
Publication date:
August 17, 2023
Applicant:
Mallinckrodt Hospital Products IP Unlimited Company
Abstract: A valve assembly comprising a housing and a valve, the valve being disposed within the housing, a first indexed member integral to the housing, the first indexed member adapted to be complementary to a second indexed member, and a radio frequency identification device adapted to communicate with a radio frequency receiver, the valve being configured to align with a canister, seal the canister and open in a single movement. A drug containment device having said valve assembly is also disclosed.
Type:
Application
Filed:
October 25, 2021
Publication date:
February 10, 2022
Applicant:
Mallinckrodt Hospital Products IP Unlimited Company
Inventors:
Frederick J. Montgomery, Duncan P. Bathe, Daniel J. Lee, Scott I. Biba, Todd J. Bakken
Abstract: Methods and systems for delivering a pharmaceutical gas to a patient. The methods and systems provide a known desired quantity of the pharmaceutical gas to the patient independent of the respiratory pattern of the patient over a plurality of breaths every nth breath, where n is greater than or equal to 1. The pharmaceutical gases include CO and NO, both of which are provided as a concentration in a carrier gas. The gas control system determines the delivery of the pharmaceutical gas to the patient to result in the known desired quantity (e.g. in molecules, milligrams or other quantified units) of the pharmaceutical gas being delivered. Upon completion of that known desired quantity of pharmaceutical gas over a plurality of breaths, the system can either terminate, continue, activate and alarm, etc.
Type:
Application
Filed:
March 29, 2021
Publication date:
July 15, 2021
Applicant:
Mallinckrodt Hospital Products IP Unlimited Company
Inventors:
Frederick J. Montgomery, Duncan P. Bathe
Abstract: Systems and methods of the present invention can enable high concentration NO to be delivered into ventilator breathing circuits, via a diffusing device, without generating undesirably large amounts of NO2.
Type:
Application
Filed:
January 18, 2021
Publication date:
May 13, 2021
Applicant:
Mallinckrodt Hospital Products IP Unlimited Company
Abstract: Systems and methods of the present invention can enable high concentration NO to be delivered into ventilator breathing circuits, via a diffusing device, without generating undesirably large amounts of NO2.
Type:
Grant
Filed:
September 30, 2016
Date of Patent:
January 19, 2021
Assignee:
Mallinckrodt Hospital Products IP Unlimited Company